Emphasis
The emphasis is on: simulation and development of new detector materials and methods of detection for nuclear imaging; collimators and other selective signal modulators, and readout methods that enhance the signal quality of detecting isotope emissions; designs of novel camera geometries for dedicated, general or multi-purpose imaging; and correction methods that compensate for the radiation physics properties to improve the clinical reliability of the image (reconstructions algorithms). Of interest are improvements in collimation and camera designs for SPECT, improvements and corrections for interaction events in PET detectors, enhancement to time of flight (TOF) PET image generation methods, reproducible and standardized quantification as well as new detector materials.
Relevance
The emphasized topics are meant to lead toward: improved clinical SPECT and PET cameras or next-generation camera systems; novel simulations, reconstruction algorithms, or artifact corrections for enhancing diagnostic images; and multi-modal camera designs. Investigating the associated dosimetry estimations leads to decreased risk in diagnostic imaging studies in patients.
Examples of emphasis
- evaluation of new semiconductor, scintillation and other novel radiation detectors
- replacing photomultiplier tubes with novel photoconversion techniques
- readout electronics for measuring radiation interactions
- techniques for improved camera spatial resolution and sensitivity
- new approaches for improving coincidence measurements for TOF-PET
- application of secondary emissions (e.g. bremsstrahlung, Cherenkov) for imaging
- novel camera designs applicable to dedicated imaging of specific organs
- combining modalities for clinically relevant hybrid systems (e.g. coupling SPECT and PET to x-ray/ultrasound CT and/or to MRI or other modalities)
- software algorithms and imaging protocols to estimate patient dosimetry
- design of improved spatial and temporal resolution SPECT systems
- methods of measuring and correcting for patient motion
- new diagnostics applied to image-guided therapy and theranostics
Notes
- clinical application of image-guided therapy and theranostics is supported by the Image-Guided Interventions program
- development of novel imaging molecular agents is supported by the Molecular Imaging program
- novel evaluation of images
Notice of Special Interest in Radiation Monitoring for Trauma Care
Related News
High-intensity electrical pulses have been medically used to destroy tumors while sparing healthy tissue. But lower-intensity pulses may have a different effect — they reshape the battlefield, making tumors more vulnerable to the body’s own defenses.
Researchers at Virginia Tech have discovered that these lower-intensity pulses alter the tumor’s environment, increasing blood vessel density within a day of treatment and boosting lymphatic vessel growth by day three. These changes may help guide immune cells to the tumor, potentially improving the body's natural ability to fight cancer. Source: Virginia Tech News
Scientists have transformed RNA, a biological molecule present in all living cells, into a biosensor that can detect tiny chemicals relevant to human health.
Research by Rutgers University-New Brunswick scientists centers on RNA, a nucleic acid that plays a crucial role in most cellular processes. Their work is expected to have applications in the surveillance of environmental chemicals and, ultimately, the diagnosis of critical diseases including neurological and cardiovascular diseases and cancer. Source: Rutgers Today
Drug-carrying DNA snippets called aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers at the University of Illinois Urbana-Champaign report.
The aptamers — short single-strand snippets of DNA that can target molecules like larger antibodies do — not only deliver cancer-fighting drugs, but also are themselves toxic to the cancer stem cells, the researchers said.
Brain cancer is the second most common cancer in children after leukemia, and it is also the deadliest, due to the fact that brain tumors are diverse, resistant to treatments and often hard to access surgically. A collaborative team of researchers at several institutions have developed a new way to profile brain cancers in children, paving the way for improved diagnostics and treatments. Source: UTSA Today
Many cancer drugs fail to penetrate deep into tumors, but new research suggests magnetism could help pull them through.